 KLEW | Novartis drug Afinitor gets EU nod for breast cancer. Full Article Reuters India The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. American health regulators also backed the drug as a breast cancer treatment ... Novartis drug AfinitorĀ® approved by European Commission to treat patients with ... Novartis drug AfinitorR approved by European Commission to treat patients with ... Afinitor approved by EU to Treat Most Common form of Advanced Breast Cancer |
